Navigation Links
Excalibur International Marine (49% Owned by EFT BioTech Holdings) Completes Inaugural Passenger Crossing of Taiwan Strait
Date:6/30/2009

CITY OF INDUSTRY, Calif. and HONG KONG, June 30 /PRNewswire-FirstCall/ -- EFT BioTech Holdings, Inc. (Pink Sheets: EFTB), announced today that Excalibur's Ocean LaLa has successfully completed its inaugural Taiwan Strait passenger voyage which has been highlighted in multiple news articles and internet news sites, including the Taiwan Sun, and the Qatar Tribune. The article states:

"A Taiwan company launched a cruise service with China on Sunday, making it the first such cross-strait service in 60 years.

"With a band playing and dragon dance performing on shore, the 2,292-tonne Ocean LaLa set sail from the Taichung Harbour for Xiamen, China, carrying 179 passengers and 23 crew.

"The voyage across the Taiwan Strait takes only four-and-a-half-hours, but it took Taiwan and China 60 years to ease tension and for Taipei to agree to lift the ban on sea links with the mainland."

The Excalibur International Marine Corp, operator of the cruise service, said that in the initial stage, the Taichung-Xianmen cruise is an irregular service chartered by travel agencies.

"Eventually it will become a regular cruise service going not only to Xiamen, but also to other Chinese ports like Fuzhou and Shanghai," said Han Chih-yang, Excalibur's deputy.

"We are full of confidence for the future of cross-strait tourism, so we are seeking to buy two larger ships for launching regular cross-strait service," he said.

Jack Qin, the President and CEO of EFT BioTech Holdings, stated, "We are excited to be recognized by the world press and this article shows that people are truly interested in this much needed passenger and cargo service."

About EFT BioTech Holdings, Inc.

EFT BioTech Holdings, Inc. is a Nevada holding company which conducts its business through its wholly-owned subsidiary, EFT Biotech Holdings, Inc., and its wholly owned subsidiaries and various vested interests. EFT BioTech Holdings, Inc. is an e-commerce company serving consumers with EFT's "made in USA" neutraceuticals, health and beauty EFT branded products through its proprietary online business platform and website, www.eftb.us. Although our products are available for sale throughout the world, most affiliates and consumers are located in China and Hong Kong. The contents of the Company's website are not incorporated by reference herein.

Safe Harbor for Forward-Looking Statements

Statements made in this release with the respect to the Company's current plans, estimates, strategies and beliefs and other statements that are not historical are forward-looking statements. Forward-looking statements include, but are not limited to, those statements using words such as "believe," "expect," "plans," "strategy," prospects," "forecast," "estimate," "project," "anticipate," "aim," "may" or "might" and words of similar meaning in connection with a discussion of future operations, financial performance, events or conditions. From time to time, oral or written forward-looking statements may also be included in other materials released to the public. These statements are based on management's assumptions and belief in light of the information currently available to it. The company cautions you that a number of important risks and uncertainties could cause actual results to materially differ from those discussed in the forward-looking statements, and therefore, you should not place undue reliance on them. You also should not rely on any obligation of the Company to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The company disclaims any such obligation unless required by law. Risks and uncertainties that might affect the Company include, but are not limited to (i) the global economic environment in which the Company operates, as well as the economic conditions in the Company's markets, (ii) levels of consumer spending, and (iii) exchange rates, particularly between the Chinese Yen and the U.S. Dollar. Risks and uncertainties also include the impact of any future events with material adverse impacts.

    For More Information, Please Contact:
    Aero Strategic Advisory, A division of Aero Financial, Inc.
    Ed Carter
    Telephone: 702-982-7732


'/>"/>
SOURCE EFT BioTech Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Excalibur - Transforming Biotech Deals can Still be Achieved
2. Excalibur Celebrates PIramed Sale With Substantial Cash Return to Investors
3. Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita-based Center of Excellence with Global Convenience(TM)
4. International Products Corp.s Lab Offers Filter Membrane Compatibility and Studies
5. Cord Blood America Continues International Expansion
6. PAREXEL International to Present at the Wachovia Equity Conference
7. BioEnergy International, LLC Announces Formation of Myriant Technologies LLC
8. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
9. NeoStem, Inc. Appoints Financial Expert with Broad International Experience to the Board of Directors and to Serve as Chairman of the Companys Audit Committee
10. Yongye Biotechnology International Receives License to Manufacture Products
11. Cynvec to Present at the 11th Annual Shanghai International Forum on Biotechnology and Pharmaceutical Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... San Diego, CA (PRWEB) , ... June 27, 2016 , ... ... mClinical solutions for clinical trials, announced today the Clinical Reach Virtual Patient ... and their care circle with the physician and clinical trial team. , Using the ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... Amgen, will join the faculty of the University of North Carolina Kenan-Flagler ... of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on the school’s ...
(Date:6/27/2016)... 27, 2016   Ginkgo Bioworks , a leading ... was today awarded as one of the World ... world,s most innovative companies. Ginkgo Bioworks is engineering ... real world in the nutrition, health and consumer ... with customers including Fortune 500 companies to design ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
Breaking Biology Technology:
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour ... from the Q1 wave of its quarterly wearables survey. ... receptivity to a program where they would receive discounts ... company. "We were surprised to see that ... LaColla , CEO of Troubadour Research, "primarily because there ...
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
Breaking Biology News(10 mins):